Nguyen Van Dang, Le Van Quang, Nguyen Thi Thu Nhung, Bui Van Giang, Ta Van To
Department of Oncology, Hanoi Medical University, Hanoi, Viet Nam.
Department of Head and Neck Radiation Oncology, Vietnam National Cancer Hospital, Hanoi, Viet Nam.
Ann Med Surg (Lond). 2022 Aug 6;80:104224. doi: 10.1016/j.amsu.2022.104224. eCollection 2022 Aug.
Multiple primary squamous cell carcinomas (MPSCs) of the oral cavity are very uncommon in clinical practice. This study describes the clinical features, imaging, and treatment characteristics of the oral cavity with MPSCs at the same time of diagnosis in our center. Besides, we review the literature and prior studies on MPSCs.
A retrospective, descriptive study from January 2019 to December 2021 was conducted on seven patients with MPSCs of the oral cavity at the time of their first diagnosis. Evaluation of the patient's characteristics, the treatment plan, the response to treatment, and the overall survival (OS).
Seven male patients ranging in age from 43 to 70 years (Mean: 53.5). Positron Emission Tomography/Computed Tomography (PET/CT) revealed a significantly increased standardized uptake value (SUV) in the index tumor (SUVi = 15.76 ± 1.96). The index tumor is often staged T3, T4; whereas the synchronous tumor is typically staged T1, T2. All patients had concurrent chemoradiotherapy (CCRT) and achieved a partial response in all cases. Mean OS was 14.71 ± 11.85 months.
MPSCs of the oral cavity at the time of diagnosis are uncommon and associated with a poor prognosis for patients. Comprehensive clinical examination, combined imaging diagnostics, with PET/CT being critical for detecting the second lesion, particularly in patients with an advanced index tumor.
口腔多原发性鳞状细胞癌(MPSCs)在临床实践中非常罕见。本研究描述了我院中心在诊断时同时患有MPSCs的口腔癌患者的临床特征、影像学表现及治疗特点。此外,我们还回顾了关于MPSCs的文献及既往研究。
对2019年1月至2021年12月首次诊断为口腔MPSCs的7例患者进行回顾性描述性研究。评估患者特征、治疗方案、治疗反应及总生存期(OS)。
7例男性患者,年龄43至70岁(平均53.5岁)。正电子发射断层扫描/计算机断层扫描(PET/CT)显示,原发肿瘤的标准化摄取值(SUV)显著升高(SUV i = 15.76 ± 1.96)。原发肿瘤常为T3、T4期;而同期肿瘤通常为T1、T2期。所有患者均接受同步放化疗(CCRT),且所有病例均获得部分缓解。平均总生存期为14.71 ± 11.85个月。
诊断时的口腔MPSCs并不常见,且患者预后较差。全面的临床检查、联合影像学诊断,尤其是PET/CT对检测第二个病灶至关重要,特别是对于原发肿瘤晚期的患者。